Tweets
"If you follow this advice👇, you will be the best speaker in the RHEUM!"
😉😊🤓
@RheumNow #ACR21 https://t.co/y2IYMFJChE
sheila @RHEUMarampa ( View Tweet )
4 years 8 months ago
Efficacy to the COVID-19 vaccine is based on both humoral (antibody) and cellular responses. Rituximab impairs B-cell response but not T-cell response to COVID-19 vaccine in auto-immune diseases @RheumNow #ACR21 8M101 Mariette X https://t.co/RoFTC6VpCt
Dr. Antoni Chan @synovialjoints ( View Tweet )
4 years 8 months ago
Prevalence of abnormal SI joint findings on MRE and MRI is 25% in Crohn's pts. Majority didn't report back pain, were female, and had intestinal complications of CD. Abs 1306 #ACR21 #RheumNow @RheumNow https://t.co/LOGoxAfrQi https://t.co/qAKC8GCLno
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 8 months ago
Abst1005 #ACR21 #ACRBest @RheumNow study identifies monocyte-derived DC population characterized as CD209+/CD14+ DC in the synovium of RA and PsA patients sensitive to JAK/STAT, but not TNF inhibition.
Olga Petryna @DrPetryna ( View Tweet )
4 years 8 months ago
VACOLUP study: COVID19 vacc, 1189 SLE pts
👉No sig. diff based on gender, age, nor type of vax
👉3.2% pts w/SLE flare
👉Flares mainly fatigue and MSK symptoms (SLE flare or side-effect of the vac?)
https://t.co/w5dYsLkk5D
#ACR21 Abst#1421 @RheumNow #ACRBest
Pedro Castillo @_Castillo_Pedro ( View Tweet )
4 years 8 months ago
Dr Keen presenting on GCA admitted to hospital. Propensity score matched to non-GCA population. Increased all cause mortality compared to general population in Western Australia (aHR 1.13). Most pronounced in early years after diagnosis. Abstr#1393 #ACR21 @RheumNow https://t.co/laW8mxp6uq
Richard Conway @RichardPAConway ( View Tweet )
4 years 8 months ago
Dr Björn Bühring highlights the burden of #multimorbidity and particularly #sarcopenia in older patients with #rheumatoidarthritis.
#ACR21 @RheumNow https://t.co/3xGtx48DAU
Mrinalini Dey @DrMiniDey ( View Tweet )
4 years 8 months ago
Majority of rheum pts on csDMARDs, TNFi, JAKi & TCZ had adequate serologic response to m-RNA based vaccines. Poor vaccine reactivity mainly assoc'd w/ RTX, steroids, and MMF. Study did not include ABA. Abs 1087 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/q4C66Htz5a https://t.co/MS7cqdFWBi
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 8 months ago
Abst1083 #acr21 #ACRBest @RheumNow study of COVID-19 outcomes in pts w/systemic auto inflammatory disease:31% had a flare of underlying SAID, either concurrently (20%) or after recovering from COVID-19 (11%). The majority of SAID pts w/COVID-19 reported mild to moderate illness https://t.co/qzYfmYpA25
Olga Petryna @DrPetryna ( View Tweet )
4 years 8 months ago
Important to properly assess #sarcopenia in older patients with #RA. Useful tools include:
👉🏼SARC-F questionnaire (≥ 4 is abnormal)
👉🏼Muscle function tests incl Short Physical Performance Battery
#ACR21 @RheumNow https://t.co/9l6b7tJ1xC
Mrinalini Dey @DrMiniDey ( View Tweet )
4 years 8 months ago
Retrospective French case study showed PAH is rare but potentially severe complication of AOSD. In this trial of 13, it only affected women. Further studies needed! Abs 1100 #ACR21 #RheumNow @RheumNow https://t.co/6CufqRV0Qg https://t.co/h73mxsJswi
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 8 months ago
Abst1094 #acr21 @RheumNow rheum pts and extremely ⬆️ESR: infection vs flare: Thrombocyte, MCV, albumin and total protein were significantly lower in infection group, however; neutrophil, MPV, CRP and ferritin were significantly lower in flare-up group https://t.co/C6MQo86Ljb
Olga Petryna @DrPetryna ( View Tweet )
4 years 8 months ago
